Pancreatic surgery for adenocarcinoma

Current Opinion in Gastroenterology

Volumn 28, Issue 5, 2012, Pages 488-493

  Warshaw, Andrew L ^a   Lillemoe, Keith D ^a   Fernandez Del Castillo, Carlos ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

pancreatectomy; pancreatic cancer; pancreatic surgery

Indexed keywords

CISPLATIN; FLUOROURACIL;

CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER INVASION; CANCER SURVIVAL; COST UTILITY ANALYSIS; HUMAN; LAPAROSCOPIC SURGERY; MINIMALLY INVASIVE SURGERY; PALLIATIVE THERAPY; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION; PANCREAS SURGERY; POSTOPERATIVE COMPLICATION; REVIEW; ROBOTICS; STENT; SURGICAL TECHNIQUE; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

ADENOCARCINOMA; HUMANS; LAPAROSCOPY; NEOADJUVANT THERAPY; PALLIATIVE CARE; PANCREATECTOMY; PANCREATIC NEOPLASMS; ROBOTICS;

EID: 84865451721     PISSN: 02671379     EISSN: 15317056     Source Type: Journal    
DOI: 10.1097/MOG.0b013e3283567f2c     Document Type: Review

References (56)

1. Lemmens VEPP, Bosscha K, van der Schelling G, et al. Improving outcome for patients with pancreatic cancer through centralization. Br J Surg 2011; 98:1455-1462.
2. Hatzaras I, Schmidt C, Klemanski D, et al. Pancreatic resection in the octogenarian: a safe option for pancreatic malignancy. J Am Coll Surg 2011; 212:373-377.
3. Lahat G, Sever R, Lubezky N, et al. Pancreatic cancer: surgery is a feasible therapeutic option for elderly patients. J Surg Oncol 2011; 9:10.
4. Ljungman D, Lundholm K, Hyltander A. Cost-utility estimation of surgical treatment of pancreatic carcinoma aimed at cure. World J Surg 2011; 35:662-670.
5. Pop GH, Richter JA, Sauer B, et al. Bridge to surgery using partially covered self-expandable metal stents (PCMS) in malignant biliary stricture: an acceptable paradigm? Surg Endosc 2011; 25:613-618.
6. Siddiqui AA, Mehendiratta V, Loren D, et al. Fully covered self-expandable metal stents are effective and safe to treat distal malignant biliary strictures, irrespective of surgical respectability status. J Clin Gastroenterol 2011; 45:824-827.
7. Glant JA, Waters JA, House MG, et al. Does the interval from imaging to operation affect the rate of unanticipated metastasis encountered during operation for pancreatic adenocarcinoma? Surgery 2011; 607-616.
8. Barbier L, Turrini O, Gregoire E, et al. Pancreatic head resectable adenocarcinoma: preoperative chemoradiation improves local control but does not affect survival. HPB (Oxford) 2011; 13:64-69.
9. Artinyan A, Anaya DA, McKenzie S, et al. Neoadjuvant therapy is associated with improved survival in resectable pancreatic adenocarcinoma. Cancer 2011; 117:2044-2049.
10. Stokes JB, Nolan NJ, Stelow EB, et al. Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer. Ann Surg Oncol 2011; 18:619-627.
11. Assifi MM, Ma XL, Eibl G, et al. Neoadjuvant therapy in pancreatic adenocarinoma: a meta-analysis of phase II trials. Surgery 2011; 150:466-473.
12. Bickenbach KA, Gonen M, Tang LH, et al. Downstaging in pancreatic cancer: a matched analysis of patients resected following systemic treatment of initially locally unresectable disease. Ann Surg Oncol 2012; 19:1663-1669.
13. Barugola G, Partelli S, Crippa S, et al. Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy. Am J Surg 2012; 203:132-139.
14. Hartwig W, Hackert T, Hinz U, et al. Pancreatic cancer surgery in the new millennium. Ann Surg 2011; 254:311-319.
15. Crippa S, Tamburrino D, Partelli S, et al. Total pancreatectomy: indications, different timing, and perioperative and long-term outcomes. Surgery 2011; 149:79-86.
16. Burdelski CM, Reeh M, Bogoevski D, et al. Multivisceral resections in pancreatic cancer: identification of risk factors. World J Surg 2011; 35:2756-2763.
17. Pavlidis TE, Pavlidis ET, Sakantamis AK. Current opinion on lymphadenectomy in pancreatic cancer surgery. Hepatobiliary Pancreat Dis Int 2011; 10:21-25.
18. Ikegami T, Maeda T, Oki E, et al. Antegrade en bloc distal pancreatectomy with plexus hanging maneuver. J Gastrointest Surg 2011; 15:690-693.
19. Addeo P, Marzano E, Rosso E, Pessaux P. Hanging maneuver during pancreaticoduedenectomy: a technique to improve R0 resection. Surg Endosc 2011; 25:1697-1698.
20. Ferreira N, Oussoultzoglou E, Fuchshuber P, et al. Splenic vein-inferior mesenteric vein anastomosis to lessen left-sided portal hypertension after pancreaticodueodenectomy with concomitant vascular resection. Arch Surg 2011; 146:1375-1381.
21. Mollberg N, Rahbari NN, Koch M, et al. Arterial resection during pancreatectomy for pancreatic cancer. Ann Surg 2011; 254:882-893.
22. Bachellier P, Rosso E, Lucescu I, et al. Is the need for an arterial resection a contraindication to pancreatic resection for locally advanced pancreatic adenocarcinoma? A case-matched controlled study. J Surg Oncol 2011; 103:75-84.
23. Bockhorn M, Burdelski C, Bogoevski D, et al. Arterial en bloc resection for pancreatic carcinoma. Br J Surg 2011; 98:86-92.
24. Yamamoto Y, Sakamoto Y, Ban D, et al. Is celiac axis resection justified for T4 pancreatic body cancer? Surgery 2012; 151:61-69.
25. Takahashi Y, Kaneoka Y, Maeda A, Isogai M. Distal pancreatectomy with celiac axis resection for carcinoma of the body and tail of the pancreas. World J Surg 2011; 35:2535-2542.
26. Denecke T, Andreou A, Podrabsky P, et al. Distal pancreatectomy with en bloc resection of the celiac trunk for extended pancreatic tumor disease: an interdisciplinary approach. Cardiovasc Intervent Radiol 2011; 34:1058-1064.
27. Waters JA, Schnelldorfer T, Aguilar-Saavedra JR, et al. Survival after resection for invasive intraductal papillary mucinous neoplasm and for pancreatic adenocarcinoma: a multiinstitutional comparison according to American Joint Committee on Cancer Stage. J Am Coll Surg 2011; 213:275-283.
28. Cho CS, Kooby DA, Schmidt CM, et al. Laparoscopic versus open left pancreatectomy: can preoperative factors indicate the safer techniques? Ann Surg 2011; 253:975-980.
29. Song BK, Kim SC, Park JB, et al. Single-center experience of laparoscopic left pancreatic resection in 359 consecutive patients: changing the surgical paradigm of left pancreatic resection. Surg Endosc 2011; 25:3364-3372.
30. Fox AM, Pitzul K, Bhojani F, et al. Comparison of outcomes and costs between laparoscopic distal pancreatectomy and open resection at a single center. Surg Endosc 2012; 26:1220-1230.
31. Gumbs AA, Rodriguez Rivera AM, Milone L, et al. Laparoscopic pancreatoduodenectomy: a review of 285 published cases. Ann Surg Oncol 2011; 18:1335-1341.
32. Zeh HJ, Zureikat AH, Secrest A, et al. Outcomes after robotic-assisted pancreaticoduodenectomy for periampullary lesions. Ann Surg Oncol 2012; 19:864-870.
33. Zhou N, Chen J, Liu Q, et al. Outcomes of pancreatoduodenectomy with robotic surgery versus open surgery. Int J Med Robotics Comput Assist Surg 2011; 7:131-137.
34. Addeo P, Marzano E, Nobili C, et al. Robotic central pancreatectomy with stented pancreaticogastrostomy: operative details. Int J Med Robotics Comput Assist Surg 2011; 7:293-297.
35. Kang CM, Kim DH, Lee WJ, et al. Initial experiences using robot-assisted central pancreatectomy with pancreaticogastrostomy: a potential way to advanced laparoscopic pancreatectomy. Surg Endosc 2011; 25:1101-1106.
36. Ramsey AM, Martin RC. Body mass index and outcomes from pancreatic resection: a review and meta-analysis. J Gastrointest Surg 2011; 15:1633-1642.
37. Pessaux P, Sauvanet A, Mariette C, et al. External pancreatic duct stent decreases pancreatic fistula rate after pancreaticodueodenectomy: prospective multicenter randomized trial. Ann Surg 2011; 253:879-885.
38. Yang SH, Dou KF, Sharma N, Song WJ. The methods of reconstruction of pancreatic digestive continuity after pancreaticoduodenectomy: a metaanalysis of randomized controlled trials. World J Surg 2011; 35:2290-2297.
39. Zhou Y, Yang C, Wang S, et al. Does external pancreatic duct stent decrease pancreatic fistula rate after pancreatic resection? A meta-analysis. Pancreatology 2011; 11:362-370.
40. Kuroki T, Tajima Y, Ditasato A, et al. Stenting versus nonstenting in pancreaticojejunostomy. Pancreas 2011; 40:25-29.
41. Tani M, Kawai M, Hirono S, et al. Use of omentum or falciform ligament does not decrease complications after pancreaticoduodenectomy: nationwide survey of the Japanese Society of Pancreatic Surgery. Surgery 2012; 151:183-191.
42. Diener MK, Seiler CM, Rossion I, et al. Efficacy of stapler versus hand-sewn closure after distal pancreatectomy (DISPACT): a randomised, controlled multicentre trial. Lancet 2011; 377:1514-1522.
43. Sepesi B, Moalem J, Galka E, et al. The influence of staple size on fistula formation following distal pancreatectomy. J Gastrointest Surg 2012; 16:267-274.
44. Ding X, Zhu J, Zhu M, et al. Therapeutic management of hemorrhage from visceral artery pseudoaneurysms after pancreatic surgery. J Gastrointest Surg 2011; 15:1417-1425.
45. Schafer M, Heinrich S, Pfammatter T, Clavien PA. Management of delayed major visceral arterial bleeding after pancreatic surgery. HPB (Oxford) 2011; 13:132-138.
46. Roulin D, Cerantola Y, Demartines N, Schafer M. Systemic review of delayed postoperative hemorrhage after pancreatic resection. J Gastrointest Surg 2011; 15:1055-1062.
47. Kollmar O, Sperling J, Moussavian MR, et al. Delayed gastric emptying after pancreaticoduodenectomy: influence of the orthotopic technique of reconstruction and intestinal motilin receptor expression. J Gastrointest Surg 2011; 15:1158-1167.
48. Kawai M, Tani M, Hirono S, et al. Pylorus ring resection reduces delayed gastric emptying in patients undergoing pancreatoduodenectomy. Ann Surg 2011; 253:495-501.
49. Fujii T, Kanda M, Kodera Y, et al. Preservation of the pyloric ring has little value in surgery for pancreatic head cancer: a comparative study comparing three surgical procedures. Ann Surg Oncol 2012; 19:176-183.
50. Nagai S, Fujii T, Kodera Y, et al. Impact of operative blood loss on survival in invasive ductal adenocarcinoma of the pancreas. Pancreas 2011; 40:3-9.
51. Kamphues C, Bova R, Schricke D, et al. Postoperative complications deteriorate long-term outcome in pancreatic cancer patients. Ann Surg Oncol 2012; 19:856-863.
52. Kneuertz PJ, Cunningham SC, Cameron JL, et al. Palliative surgical management of patients with unresectable pancreatic adenocarcinoma: trends and lessons learned from a large, single institution experience. J Gastrointest Surg 2011; 15:1917-1927.
53. Tachezy M, Bockhorn M, Gebauer F, et al. Bypass surgery versus intentionally incomplete resection in palliation of pancreatic cancer: is resection the lesser evil? J Gastrointest Surg 2011; 15:829-835.
54. Gillen S, Schuster T, Friess H, et al. Palliative resections versus palliative bypass procedures in pancreatic cancer: a systematic review. Am J Surg 2011; 203:499-502.
55. Walter J, Nier A, Rose T, et al. Palliative partial pancreaticoduodenectomy impairs quality of life compared to bypass surgery in patients with advanced adenocarcinoma of the pancreatic head. EJSO 2011; 37:798-804.
56. Arnaoutakis GJ, Rangachari D, Laheru DA, et al. Pulmonary resection for isolated pancreatic adenocarcinoma metastasis: an analysis of outcomes and survival. J Gastrointest Surg 2011; 15:1611-1617.